Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverVASO
HealthcareOQXUSD

Vaso Corporation

$00123456789.0012345678900123456789+5.3%
52w low (est.) $0.16$0.25 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD33.44M
52w range
USD0.11 - USD0.25
Beta
0.59
Sector
Healthcare
Data quality
92/100
Valuation
P/E ratio
19.0x
DCF fair value
USD0.16
Margin of safety
-20.0%
Quality & efficiency
Moat score
41/100
Return on equity
6.4%
Profit margin
2.0%
Debt / equity
0.08
Growth & analysts
Revenue growth
-0.5%
Run the 10-point checklist before you buy How these numbers are made

About Vaso Corporation

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed network infrastructure, such as routers, switches, and other core equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Valuation

ValueGrowthProfitHealthIncome31QUALITY
Overall Rating
38
Reduce
Reduce

Derived from filed metrics · High confidence (92% of the inputs available)

Moat Score41
DCF Intrinsic Value
USD0.16-20.0% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD33.44M
P/E Ratio
19.0
Dividend Yield
0.00%
Revenue Growth
-0.5%
Profit Margin
2.0%
ROE
6.4%
Debt / Equity
0.08
Beta
0.59
vs Healthcare sector:P/E 19 vs 28 · cheaperMoat 41 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · VASO